|
 Many women take tremendous amounts of soy thinking it will prevent
breast cancer based on epidemiological studies, said lead author Dr.
Moshe Shike of Memorial Sloane Kettering Cancer Center in New York.
Some studies of Asian populations have found that as soy intake
increased, breast cancer risk decreased, but those studies couldn’t
prove a beneficial effect of soy - they could only identify an
association, Shike said.
The new study, however, looked at women who had already been
diagnosed with breast cancer.
Soybeans contain phytoestrogens, which can mimic, at least weakly,
some effects of the hormone estrogen – and “estrogen is no good at
any time after breast cancer diagnosis,” said V. Craig Jordan of the
Georgetown University Lombardi Comprehensive Cancer Center in
Washington, D.C., in a phone interview.
Most breast cancers, including all those in the new trial, are
estrogen-receptor positive, meaning the tumors may respond to
signals from estrogen in the body.
For that reason, as soon as a woman is diagnosed with breast cancer,
she will be asked to avoid hormones and will usually receive
anti-estrogenic drugs like tamoxifen after surgery, said Jordan, who
wrote a commentary accompanying the new study.
With support from the Breast Cancer Research Foundation, Shike and
his coauthors studied changes in the molecular structure of
early-stage breast cancer cells obtained from biopsies done at
diagnosis and again few weeks later, when the tumor was removed.
The 140 women in the study were taking either soy protein or milk
protein supplements in the meantime, in the form of two 25.8 gram
packets mixed into water or juice each day.
Compared to tumors in the milk group, the tumors in the soy group
were “overexpressing” genes associated with the cell cycle and cell
proliferation. Overexpression means the effects of those genes could
possibly be stronger.
For some in the soy group, expression of a gene associated with
cancer growth increased, too, the authors reported in the Journal of
the National Cancer Institute.
[to top of second column] |
The study only looked at tumor changes on a genetic level – not at
how tumors grew or didn’t grow in each individual woman.
It’s not clear what made those women in particular respond to soy
protein, Shike told Reuters Health by phone.
“All we can say is that in some of the women, the soy component
drove proliferative genes, at the gene level,” he said. “How it
would translate into cancer outcome we can’t say.”
“What we recommend is moderation, meaning we think that taking
excessive amounts of soy may not be a good idea,” Shike said. “We
don’t have clinical proof for that because this is only gene
expression.”
In the commentary, Jordan suggests that estrogen may have different
effects on breast cancer based on a woman’s stage of life, whether
she is in menopause or after menopause has ended.
“For populations of women with breast cancer, soy products aren’t
good,” Jordan said. “Now doctors have a set practice and can tell
patients that this isn’t a good thing.”
SOURCES: http://bit.ly/1xzrIXF
and http://bit.ly/1rvUvnp
Journal of the National Cancer Institute, September 4, 2014.
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
